2095417-39-1
2095417-39-1
Chemical Structure
1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine
- CAS No.: 2095417-39-1
- Formula:C12H13N5O4
- Molecular Weight:291.26
IUPAC Name: (2R,3R,4R,5R)-2-(hydroxymethyl)-5-(3H-imidazo[2,1-i]purin-3-yl)tetrahydrofuran-3,4-diol
InChIKey: LRPBXXZUPUBCAP-IQEPQDSISA-N
SMILES: OC[C@@H]1[C@H](O)[C@@H](O)[C@H](N2C(N=CN3C4=NC=C3)=C4N=C2)O1
Biological Activity: 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine | 1,N6-Etheno-9-(β-D-xylofuranosyl)adenosine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
